Emergency Department-initiated Buprenorphine and Referral to Follow-up Addiction Care: A Program Description

J Addict Med. 2022 Mar-Apr;16(2):216-222. doi: 10.1097/ADM.0000000000000875.

Abstract

Introduction: Emergency department (ED) initiated opioid use disorder (OUD) care is effective; however, real-world predictors of patient engagement are lacking.

Objective: This program evaluation examined predictors of ED-based OUD treatment and subsequent engagement.

Method: Program evaluation in Boston, MA. Adult patients who met criteria for OUD during an ED visit in 2019 were included. Patients were included if a diagnosis of OUD or opioid-related overdose was associated with the ED visit or if they met previously validated criteria for OUD within the previous 12 months. We assessed predictors of ED-OUD treatment receipt and subsequent engagement, using Healthcare Effectiveness Data and Information Set definition of initial encounter within 14 days of discharge and either 2 subsequent encounters or a subsequent buprenorphine prescription within 34 days of the initial encounter. We used generalized estimating equations for panel data.

Results: During 2019, 1946 patients met criteria for OUD. Referrals to Bridge Clinic were made for 207 (11%), buprenorphine initiated for 106 (5%), and home induction buprenorphine kits given to 56 (3%). Following ED discharge, 237 patients (12%) had a visit within 14 days, 122 (6%) had ≥2 additional visits, and 207 (11%) received a subsequent buprenorphine prescription. Young, White, male patients were most likely to receive ED-OUD care. Patients who received ED-OUD care were more likely to have subsequent treatment engagement (adjusted rate ratio: 2.30, 95% confidence intervals: 1.62-3.27). Referrals were made less often than predicted for Black (-49%) or Hispanic/Latinx (-25%) patients.

Conclusions: Initiating treatment for OUD in the ED was associated with increased engagement in outpatient addiction care.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Buprenorphine* / therapeutic use
  • Emergency Service, Hospital
  • Follow-Up Studies
  • Humans
  • Male
  • Opioid-Related Disorders* / drug therapy
  • Program Development
  • Referral and Consultation

Substances

  • Buprenorphine